BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3142824)

  • 1. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic therapy with tissue-type plasminogen activator].
    Toma M; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic hemorrhage: a complication of tissue plasminogen activator treatment.
    Cheung PK; Arnold JM; McLarty TD
    Can J Cardiol; 1990 Jun; 6(5):183-5. PubMed ID: 2116935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator in acute myocardial infarction: role of the critical care nurse.
    Kline EM
    Heart Lung; 1987 Nov; 16(6 Pt 2):779-86. PubMed ID: 2960639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinfarction after thrombolytic therapy. Results obtained with readministration of thrombolytic agent in 3 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1993 Mar; 60(3):177-82. PubMed ID: 8250747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 13. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of intravenous thrombolysis prior to percutaneous coronary intervention in reperfusion therapy for acute myocardial infarction].
    Uto K; Ota Y; Mizuno M; Nakamura A; Nakajima R; Endoh Y; Kasanuki H
    J Cardiol; 2002 Dec; 40(6):241-8. PubMed ID: 12528645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myocardial infarction and coronary thrombolysis].
    Kanmatsuse K
    Rinsho Ketsueki; 1996 Sep; 37(9):813-6. PubMed ID: 8914468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.
    Becker RC; Corrao JM; Harrington R; Ball SP; Gore JM
    Am Heart J; 1991 Jan; 121(1 Pt 1):220-44. PubMed ID: 1898680
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolytic therapy for myocardial infarction.
    Andreotti F
    N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Front-loaded infusion therapy of rT-PA during active menstruation. A case report.
    Lee DW; Garza JL
    Angiology; 1994 Apr; 45(4):311-4. PubMed ID: 8161010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.